For the fourth quarter (end-September 28), Hologic finished with revenue of $865.8 million, up 6.4% from sales of $813.5 million in the same period of 2018. The company's net income for the quarter was $39.9 million, which included a noncash impairment charge of $79.2 million. The company's net income was $50.5 million in the fourth quarter of 2018.
Hologic reported that its Breast Health segment turned in revenue of $342.6 million, up 6.3% after currency adjustment from sales of $322.2 million in the fourth quarter of 2018. The company's Diagnostics business reported fourth-quarter revenue of $306.8 million, up 6.2% from sales of $288.9 million in the same period of 2018, which Hologic said represented "robust" growth.
For the year, Hologic recorded revenue of $3.367 billion, compared with $3.218 billion for fiscal 2018. The company posted a loss for the year of $40.2 million, compared with a loss of $111.3 million in 2018. The 2019 numbers include asset impairment charges of $523 million, compared with impairment charges of $731.7 million in fiscal 2018. Both charges were related to write-downs for the company's Cynosure business, a medical aesthetics firm that Hologic bought in 2017.
Copyright © 2019 AuntMinnie.com